Similar articles

• The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.

  Splinter TA, Scher HI, Denis L, Bukowski R, Soloway M, Vogelzang N, Klimberg I, Dalesio O, Herr H. Splinter TA, et al. Prog Clin Biol Res. 1990;353:219-24. Prog Clin Biol Res. 1990. PMID: 2217422 Clinical Trial. No abstract available.
• [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].

  Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A. Zapatero A, et al. Arch Esp Urol. 1997 Jun;50(5):448-54; discussion 454-6. Arch Esp Urol. 1997. PMID: 9382586 Spanish.
• Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

  George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. George L, et al. Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088. Urology. 2004. PMID: 15351577 Review.
• The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.

  deVere White RW, Katz MH, Steinberg GD. deVere White RW, et al. J Urol. 2009 May;181(5):1994-7. doi: 10.1016/j.juro.2009.02.052. Epub 2009 Mar 14. J Urol. 2009. PMID: 19286209 Review. No abstract available.
• Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.

  Novara G, De Marco V, Gottardo F, Dalpiaz O, Bouygues V, Galfano A, Martignoni G, Patard JJ, Artibani W, Ficarra V. Novara G, et al. Cancer. 2007 Oct 15;110(8):1715-22. doi: 10.1002/cncr.22970. Cancer. 2007. PMID: 17724728